Prevention of cervical cancer: Where immunology meets diagnostics

Immunology Letters

Volumn 122, Issue 2, 2009, Pages 126-127

  Meijer, Chris J L M ^a   Heideman, Daniëlle A M ^a   Berkhof, Hans ^a   Snijders, Peter J F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; HPV DNA testing; Human papillomavirus; Primary prevention; Prophylactic vaccination; Secondary prevention

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE; VIRUS ANTIBODY;

CANCER DIAGNOSIS; CANCER IMMUNIZATION; CANCER IMMUNOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; DNA SCREENING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; UTERINE CERVIX CANCER; VIRUS INFECTION; ADENOCARCINOMA; AGE; ANTIBODY PRODUCTION; ARTICLE; FEMALE; IMMUNOLOGY; MASS SCREENING; PAPILLOMAVIRUS INFECTION; PUBERTY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VACCINATION;

ADENOCARCINOMA; AGE FACTORS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PUBERTY; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 73349083091     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.11.011     Document Type: Review

References (7)

1. A.T. Lörincz R.M. Richart Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs Arch Pathol Lab Med 127 8 2003 959 968
2. J. Cuzick C. Clavel K.U. Petry C.J. Meijer H. Hoyer S. Ratnam Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 5 2006 1095 1101
3. P. Naucler W. Ryd S. Törnberg A. Strand G. Wadell K. Elfgren Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 16 2007 1589 1597
4. N.W. Bulkmans J. Berkhof L. Rozendaal F.J. van Kemenade A.J. Boeke S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 9601 2007 1764 1772
5. G. Ronco N. Segnan P. Giorgi-Rossi M. Zappa G.P. Casadei F. Carozzi Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial J Natl Cancer Inst 98 2006 765 774
6. D.M. Harper E.L. Franco C.M. Wheeler A.-B. Moscicki B. Romanowski C.M. Roteli-Martins Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial Lancet 367 2006 1247 1255
7. L.L. Villa G. Perez S.K. Kjaer J. Paavonen M. Lehtinen N. Muñoz Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 2007 1915 1927